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Abstract 
This is a report on a case of neonatal sepsis and clinical management with multiple antibiotic therapy in 
a neonatal intensive care unit (NICU) in Brazil. A preterm baby boy was born by caesarean section at 
34 weeks and two days of gestation from an oligodramnious pregnancy with intrauterine growth 
restriction. After respiratory failure detection, the baby was intubated and placed on mechanical 
ventilation for respiratory failure and was shifted to NICU. Ampicillin and gentamicin were instituted 
empirically. Enterobacter spp-induced severe sepsis was diagnosed. Included in the antibiotic therapy 
were oxacycline, amikacin, cefepime, tazocin, meropen and teicoplanin. After sixty days in NICU, 
clinical and laboratory parameters were normalized and the baby recovered. The empirical long-term 
antibiotic treatment and the use of broad spectrum antibiotics, as observed in the present case, should 
be carefully considered in newborns admitted to NICU.  
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Neonatal bacterial sepsis, classified as early or 
late onset, is a major cause of morbidity and 
mortality, particularly for premature neonates, 
being an important public health concerns 
worldwide [1]. Very low birth weight infants 
(VLBW), weighing between 500 and 1500 g are 
known to have a high risk of acquiring sepsis [2], 
despite many advances in obstetrical and 
neonatal care [2]. The incidence of neonatal 
sepsis in developed countries ranged from 10-25 
% of all infants and reached up to 50 % in VLBW 
infants [1]. Neonatal infections are considered 
infections derived either intrapartum from the 
mother’s flora, or acquired in the hospital 
[3].Early onset neonatal sepsis (EOS) occurs in 
the first three days of life, which is typically 
caused by organisms transmitted vertically from 
the mother to the infant before or at the time of 
birth [4]; while late onset neonatal sepsis (LOS), 
an infection occurring after day 3 of life, is more 
likely to be caused by pathogens acquired during 
the course of hospital care. Besides higher risk of 
mortality caused by neonatal sepsis, survivors of 
neonatal sepsis may develop severe morbidity 
secondary to concomitant meningitis or from 
hypoxemia resulting from persistent pulmonary 
hypertension, septic shock, and respiratory 
failure [5]. Early onset neonatal sepsis (EOS) is 
reported to be caused primarily by Streptococcus 
agalactiae and Escherichia coli in high income 
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countries [6]. In developing countries, bacteria 
like Klebsiella spp., Escherichia coli, and 
Staphylococcus aureus are reported to be the 
main cause reason of neonatal sepsis within the 
first week of life [7]. The spectrum of bacteria 
seen in early onset newborn sepsis also depends 
on the gestational week [8]. In mothers who 
received intrapartum or prepartum antibiotic 
treatment, there is likelihood to encounter 
infections with Enterobacter or Klebsiella spp. [5]. 
In recent years, the incidence of infections with 
Gram-negative rods such as Escherichia coli, 
Enterobacter spp, and Klebsiella spp seemed to 
increase in many neonatal intensive care unit 
(NICU) worldwide [5].  
 
Enterobacteriaceae was noted to pose an 
increasing problem in the recent years, causing 
severe nosocomial infections. Besides rapid 
diagnosis, the immediate initiation of treatment is 
of great importance for a favorable treatment 
outcome. Suspected infections are quite frequent 
in premature newborns and empirical antibiotic 
therapy is an emergency. If treatment is delayed 
or ineffective, neonatal sepsis can be rapidly 
fatal, making optimal use of antibiotics is most 
essential. Empiric antibiotic therapy in newborns 
is based on combinations of cephalosporin, 
ampicillin and gentamicin [9,10]. A prolonged 
empiric antibiotic therapy after birth, however, 
was shown to be problematic in pre-term infants. 
Thus, either toxic or subtherapeutic treatment 
courses may exist in the neonatal clinical care, 
promoting adverse reactions and antibiotic 
resistance which obviously impacts clinical 
outcomes.  
 
We report a clinical course of antibiotic therapy 




A preterm baby boy with birth weight of 2.14 kg 
was by caesarean delivery at 34 weeks and two 
days of gestation at a public hospital, in a city of 
Paraná State, Brazil, in April 2014. The 
oligodramnious pregnancy of twins was 
diagnosed with intrauterine growth restriction and 
presence of grade II placenta. One of the twins 
died after caesarean. The surviving infant was 
well at birth, with Apgar scores of 8 and 10, at 1 
and 5 min, respectively. The temperature was 
36.50 °C, heart rate 134-138/min, respiratory 
rate 36-46/min, perfusion < 3 s. Since the 
respiratory course deteriorated with worsening 
saturation, the baby was intubated and placed on 
mechanical ventilation for respiratory failure. On 
the second day of birth, the infant presented with 
jaundice and respiratory failure and was shifted 
to NICU. The symptoms were suggestive 
respiratory distress syndrome (RDS) or 
pulmonary infection. The hematological 
parameters and blood culture were investigated. 
Ampicillin (200 mg,i.v.,12 h) and gentamicin (9 
mg, i.v., 36 h) were instituted empirically. 
Cardiovascular drugs, such as dobutamine (6 
mg/kg/min), and opioid (fentanyl, 2 mg/kg/min) 
were administered and secondary hypertensive 
state was observed. At 6th day in the NICU, 
hypoglycemia was observed and 
thrombocytopenia was not elicited (136,000 × 
109 platelets/L). Dexamethasone (0.3mg, i.v.,6 h) 
was also introduced to avoid broncopulmonary 
dysplasia.  At 9th day, the results of blood culture 
were not yet available, bradycardia was detected 
and antibiotic therapy was changed to oxacilin 
(50 mg, i.v., 12 h) and amikacin (28 mg, i.v., 24 
h), suggesting low efficacy of gentamicin and 
ampicillin combination and urine culture was 
negative. In the following days, bradycardia was 
restored by dobutamine administration. The 
antibiotic cefepime (93 mg, i.v., 12 h) was also 
included in the treatment. The investigations 
revealed leukocytosis, thrombocytopenia (26,000 
× 109 platelets/L) and C-reactive protein. Platelet 
transfusion was required. On 15th day blood 
culture yielded, Enterobacter spp, confirming the 
diagnosis of severe sepsis. Tazocin (180 mg, 8 
h) was immediately administrated.  
 
Two days after, pneumoperitoneum was 
observed and thrombocytopenia was continuous 
(32,000 × 109 platelets/L). The appendix was 
determined as perfored and obstructed and 
appendectomy was performed. Severe 
alterations in haemogram and C-reactive protein 
were observed and in the antibiotic therapy were 
included meropenem (40 mg, i.v., 8 h) and 
teicocloplanin (20 mg; i.v., 12 h). As the clinical 
state worsened, vancomycine (30 mg, i.v., 8 h) 
and mycamine (20 mg, i.v., 24 h) were 
introduced, but it caused seizure state and ascite 
formation. Furosemide (20 mg, i.v., 12 h) was 
recommended, since oliguria and hypervolemia 
were presented. At this stage platelet level was 
8.000 × 109 platelets/L, with continuous antibiotic 
therapy. Since many drugs were used in this 
clinical case, drug–drug interaction was possible. 
However, using the Naranjo Adverse Drug 
Reaction Probability Scale, it was observed that 
a “possible adverse drug reaction” (score 4), 
related to a continuous thrombocytopenia.From 
30th and following days, clinical and laboratory 
parameters were normalized.  One month after 
discharge from NICU, the infant was in good 
general condition. 
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Data collection was done retrospectively on the 
basis of medical records. Newborn sepsis was 
defined as acquiring a sepsis within 30 days after 
birth. Early onset sepsis was defined as having a 
positive blood culture within 72 h and late onset 
sepsis after 72 h of delivery. Additionally, 
diagnosis of sepsis was based on having at least 
two clinical signs of sepsis (core temperature 
> 38.5 °C, tachycardia/bradycardia or tachypnea) 
and one positive laboratory parameter linked to 
sepsis, i.e., white blood cell count and a C-




This report was approved (approval nº 919.213-
COPEP/UEM) by Ethics Committee of State 




Early onset neonatal sepsis was reported within 
the first week of life. Many factors are involved in 
the onset of sepsis, including:  gestational age, 
caesarean or spontaneous vertex delivery, Apgar 
score and infant weight. Gram negative bacteria 
such as Enterobacter spp played an important 
role in neonatal sepsis in NICUs [5-7] 
predominantly in premature newborns with 
VLBW (below 2,500 g) and in one-third of cases, 
it was related to surgical interventions or 
previous antibiotic therapy during pregnancy 
period [12]. 
 
As microbiologically evaluated infection is rare in 
neonates, treatment has to be started as early as 
possible and merely upon clinical suspicion. 
Indeed, faster and specific tests are necessary to 
avoid the inappropriate use of antibiotics, since it 
has been reported multiresistant bacterial strain. 
Failure to recognize that resistant strains may 
result in ineffective antibiotic therapy with its 
attendant morbidity and mortality. 
 
The initial choice of antibiotic therapy will depend 
on the clinical context and local bacterial 
epidemiology. In all cases, newborns who 
acquired an infection with Enterobacteriaceaeare 
empirically treated with ampicillin, gentamicin 
and/or cephalosporin before the onset of the 
sepsis. In this context, prolonged (> 5 days) 
empirical treatment/prophylaxis with broad 
spectrum antibiotics was shown to be associated 
with a higher risk of late onset sepsis (LOS), 
necrotizing enterocolitis and mortality in preterm 
infants [11,12]. In this study, it was observed that 
the mean duration of empirical antibiotic 
treatment was 7 days. This is noteworthy in view 
of the high resistance and mortality rates often 
seen in newborns with LOS due to failure of 
empirical treatment. We can only speculate that 
some resistance was caused by strain selection 
due to long-term initial antibiotic therapy or 
passed on to the newborns via their mothers 
around birth. The present case is early onset 
sepsis and the baby could have acquired from 
the mother. At the moment it is not possible to 
give a concluding statement on this question.  
 
The possibility of a nosocomial infections 
outbreak of multi-resistant strains is argued 
against by the fact that there was no timely 
gathering of cases. Here, we are furthermore 
limited by the fact that we are not able to provide 
data about various bacterial strains involved in 
this case. Indeed, the treatment of neonatal 
sepsis is a challenge. The neonate had 
immunosuppression or debilitation because of 
prematurity, respiratory tract instrumentation, 
NICU stay and use of broad spectrum antibiotics. 
The treatment needs to be rapid, appropriate for 
the pathogen and safety of the neonate. The 
challenge seems to be increasing with each 
passing day due the escalating multidrug-
resistant organisms [9]. In practice, ampicillin or 
amoxicillin in combination with an 
aminoglycoside (amikacin or gentamicin) is the 
most common antibiotic regimen for neonatal 
sepsis.  
 
The use of many classes of antibiotics clearly 
demonstrated a possible resistance of bacteria 
involved in sepsis. In fact, the use of broad 
spectrum antibiotics in the present case may 
have resulted in antibiotic selection pressure on 
the bowel inhabitants resulting in increased 
survival and overgrowth of the resistant 
population. In case of severe infection due to 
multidrug-resistant members of the 
Enterobacteriaceae, including those with 
extended-spectrum β-lactamases (ESBLs) or 
AmpCs, carbapenems and quinolones are used 
as the last resort for treatment [12].The choice of 
antibiotics should also be based on susceptibility 
reports, type of infection being treated, the 
severity of the infection and clinical response to 




The empiric long term antibiotic treatment and 
the high number of late onset sepsis with often 
multiresistant Enterobacteriaceae might be 
causal and urges for a change in general 
antibiotic prophylaxis/treatment in newborns 
admitted to the NICU. As described in this case 
report, the findings demonstrate the need for 
strict enforcement of infection control practices, 
whereas an early microbiology screening plays a 
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pivotal role in early detection and reporting of 
antibiotic resistance. In addition, close liaison 
between the clinicians and the microbiologists 
will facilitate a significant reduction in morbidity 
and mortality in NICU. The emergence and 
spread of these pathogens can be significantly 
curtailed if appropriate infection control 
procedures, strict enforcement of antibiotic 
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